News

Drug-Eluting Stents Cut Mortality and Revascularization Rates

Publish date: December 1, 2007
PDF Download

 

Dr. Mauri has received honoraria from Abbott Vascular, Boston Scientific, Cordis, and Metronic Vascular.

Pages

Recommended Reading

Lipid-Lowering May Improve Cognition in A-Fib
MDedge Internal Medicine
Cardiac Rehab Services Are Still Underutilized
MDedge Internal Medicine
Anemia Tied to Worse Acute Coronary Syndrome Outcomes
MDedge Internal Medicine
Cardiac Catheterization a Must in PAH Diagnosis
MDedge Internal Medicine
Pulmonary Arterial Hypertension Guidelines Reflect New Data
MDedge Internal Medicine
Bosentan Slows Progression in Class II PAH
MDedge Internal Medicine
Treatment of Pulmonary Arterial Hypertension Is Evolving
MDedge Internal Medicine
Adiposity Is a Risk Factor for Ischemic Stroke
MDedge Internal Medicine
Outcomes 'Terrible' After Stent Thrombosis
MDedge Internal Medicine
Pioglitazone May Lower Risk of MI, Stroke
MDedge Internal Medicine